Compare $MCRB vs $RNAZ | Chartloom

Compare

$MCRB vs $RNAZ

Seres Therapeutics Inc · Transcode Therapeutics Inc

MCRB

Seres Therapeutics Inc

RNAZ

Transcode Therapeutics Inc

Compare $MCRB vs $RNAZ

Comparing Seres Therapeutics Inc and Transcode Therapeutics Inc

MCRBSeres Therapeutics Inc

RNAZTranscode Therapeutics Inc

MCRBSeres Therapeutics Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-82.1%

52W performance

-86.2%

FCF yield

-195.5%

RNAZTranscode Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-74.9%

52W performance

-82.4%

FCF yield

-1146.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MCRB

RNAZ

Detailed metrics comparison

MCRB

Seres Therapeutics Inc

RNAZ

Transcode Therapeutics Inc

Market Cap

MCRB$26M

RNAZ$2M

Enterprise Value

MCRB$11M

RNAZ$-6M

Price

MCRB$2.71

RNAZ$1.86

P/E Ratio

MCRBN/A

RNAZN/A

P/S Ratio

MCRB13.93x

RNAZ0.00x

EV/Sales

MCRB5.65x

RNAZ0.00x

EV/EBITDA

MCRB0.00x

RNAZ0.00x

P/B Ratio

MCRB0.85x

RNAZ0.19x

P/FCF Ratio

MCRBN/A

RNAZN/A

EV/FCF

MCRB-0.21x

RNAZ0.25x

PEG Ratio

MCRBN/A

RNAZN/A

Forward P/E (NTM)

MCRBN/A

RNAZN/A

Forward P/S (NTM)

MCRBN/A

RNAZN/A

Revenue (TTM)

MCRB$2M

RNAZ$0

Revenue Growth (YoY)

MCRBN/A

RNAZN/A

Forward Rev Growth

MCRB-98.0%

RNAZ0.0%

Gross Margin (TTM)

MCRB0.0%

RNAZ0.0%

Operating Margin (TTM)

MCRB0.0%

RNAZ0.0%

EBITDA Margin (TTM)

MCRB-3971.2%

RNAZ0.0%

Net Margin (TTM)

MCRB-1192.9%

RNAZ0.0%

FCF Margin (TTM)

MCRB-2724.1%

RNAZN/A

Net Income (TTM)

MCRB$-22M

RNAZ$-46M

FCF (TTM)

MCRB$-51M

RNAZ$-23M

EPS (TTM)

MCRB-$2.30

RNAZ-$48.35

ROE (TTM)

MCRB-6032.0%

RNAZ-3928.0%

ROA (TTM)

MCRB-1794.0%

RNAZ-3601.0%

ROIC (TTM)

MCRB-6032.0%

RNAZ-3922.0%

Cash

MCRB$16M

RNAZ$8M

Debt

MCRB$0

RNAZ$652K

Net Cash/Debt

MCRB$16M

RNAZ$8M

Current Ratio (TTM)

MCRB2.11x

RNAZ1.97x

Quick Ratio (TTM)

MCRB2.04x

RNAZ1.55x

Debt/Equity (TTM)

MCRB0.00x

RNAZ0.00x

Debt/Assets (TTM)

MCRB0.0%

RNAZ0.0%

Interest Coverage (TTM)

MCRBN/A

RNAZN/A

Net Debt/EBITDA (TTM)

MCRB0.00x

RNAZ0.00x

Beta

MCRB0.49

RNAZ1.29

52W Performance

MCRB-86.2%

RNAZ-82.4%

YTD Performance

MCRB-82.1%

RNAZ-74.9%

% from 52W High

MCRB-91.0%

RNAZ-91.1%

% from 52W Low

MCRB12.0%

RNAZ22.4%

Asset Turnover (TTM)

MCRB0.02x

RNAZ0.00x

FCF Yield (TTM)

MCRB-195.5%

RNAZ-1146.9%

Earnings Yield (TTM)

MCRB-85.6%

RNAZ-2347.6%

Dividend Yield (TTM)

MCRBN/A

RNAZN/A

Rule of 40

MCRB-2,724.1

RNAZ0.0

EV/GP/RG

MCRBN/A

RNAZN/A

Ticker research

View MCRB research View RNAZ research

Metric	MCRB Seres Therapeutics Inc	RNAZ Transcode Therapeutics Inc
Market & Valuation
Market Cap	$26M	$2M
Enterprise Value	$11M	$-6M
Price	$2.71	$1.86
P/E Ratio	N/A	N/A
P/S Ratio	13.93x	0.00x
EV/Sales	5.65x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	0.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.21x	0.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-98.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3971.2%	0.0%
Net Margin (TTM)	-1192.9%	0.0%
FCF Margin (TTM)	-2724.1%	N/A
Net Income (TTM)	$-22M	$-46M
FCF (TTM)	$-51M	$-23M
EPS (TTM)	-$2.30	-$48.35
ROE (TTM)	-6032.0%	-3928.0%
ROA (TTM)	-1794.0%	-3601.0%
ROIC (TTM)	-6032.0%	-3922.0%
Financial Health
Cash	$16M	$8M
Debt	$0	$652K
Net Cash/Debt	$16M	$8M
Current Ratio (TTM)	2.11x	1.97x
Quick Ratio (TTM)	2.04x	1.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.29
52W Performance	-86.2%	-82.4%
YTD Performance	-82.1%	-74.9%
% from 52W High	-91.0%	-91.1%
% from 52W Low	12.0%	22.4%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-195.5%	-1146.9%
Earnings Yield (TTM)	-85.6%	-2347.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,724.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MCRB research	View RNAZ research

Valuation

P/S Ratio

RNAZ

0.00x

MCRB

13.93x

EV/FCF

MCRB

-0.21x

RNAZ

0.25x

Growth & revenue

Forward Revenue Growth

RNAZ

0.0%

MCRB

-98.0%

Profitability & performance

Gross Margin

MCRB

0.0%

RNAZ

0.0%

ROE

RNAZ

-3928.0%

MCRB

-6032.0%

FCF Yield %

MCRB

-195.5%

RNAZ

-1146.9%

52-Week Performance

RNAZ

-82.4%

MCRB

-86.2%

Detailed metrics comparison

MCRB

Seres Therapeutics Inc

RNAZ

Transcode Therapeutics Inc

Market Cap

MCRB$26M

RNAZ$2M

Enterprise Value

MCRB$11M

RNAZ$-6M

Price

MCRB$2.71

RNAZ$1.86

P/E Ratio

MCRBN/A

RNAZN/A

P/S Ratio

MCRB13.93x

RNAZ0.00x

EV/Sales

MCRB5.65x

RNAZ0.00x

EV/EBITDA

MCRB0.00x

RNAZ0.00x

P/B Ratio

MCRB0.85x

RNAZ0.19x

P/FCF Ratio

MCRBN/A

RNAZN/A

EV/FCF

MCRB-0.21x

RNAZ0.25x

PEG Ratio

MCRBN/A

RNAZN/A

Forward P/E (NTM)

MCRBN/A

RNAZN/A

Forward P/S (NTM)

MCRBN/A

RNAZN/A

Revenue (TTM)

MCRB$2M

RNAZ$0

Revenue Growth (YoY)

MCRBN/A

RNAZN/A

Forward Rev Growth

MCRB-98.0%

RNAZ0.0%

Gross Margin (TTM)

MCRB0.0%

RNAZ0.0%

Operating Margin (TTM)

MCRB0.0%

RNAZ0.0%

EBITDA Margin (TTM)

MCRB-3971.2%

RNAZ0.0%

Net Margin (TTM)

MCRB-1192.9%

RNAZ0.0%

FCF Margin (TTM)

MCRB-2724.1%

RNAZN/A

Net Income (TTM)

MCRB$-22M

RNAZ$-46M

FCF (TTM)

MCRB$-51M

RNAZ$-23M

EPS (TTM)

MCRB-$2.30

RNAZ-$48.35

ROE (TTM)

MCRB-6032.0%

RNAZ-3928.0%

ROA (TTM)

MCRB-1794.0%

RNAZ-3601.0%

ROIC (TTM)

MCRB-6032.0%

RNAZ-3922.0%

Cash

MCRB$16M

RNAZ$8M

Debt

MCRB$0

RNAZ$652K

Net Cash/Debt

MCRB$16M

RNAZ$8M

Current Ratio (TTM)

MCRB2.11x

RNAZ1.97x

Quick Ratio (TTM)

MCRB2.04x

RNAZ1.55x

Debt/Equity (TTM)

MCRB0.00x

RNAZ0.00x

Debt/Assets (TTM)

MCRB0.0%

RNAZ0.0%

Interest Coverage (TTM)

MCRBN/A

RNAZN/A

Net Debt/EBITDA (TTM)

MCRB0.00x

RNAZ0.00x

Beta

MCRB0.49

RNAZ1.29

52W Performance

MCRB-86.2%

RNAZ-82.4%

YTD Performance

MCRB-82.1%

RNAZ-74.9%

% from 52W High

MCRB-91.0%

RNAZ-91.1%

% from 52W Low

MCRB12.0%

RNAZ22.4%

Asset Turnover (TTM)

MCRB0.02x

RNAZ0.00x

FCF Yield (TTM)

MCRB-195.5%

RNAZ-1146.9%

Earnings Yield (TTM)

MCRB-85.6%

RNAZ-2347.6%

Dividend Yield (TTM)

MCRBN/A

RNAZN/A

Rule of 40

MCRB-2,724.1

RNAZ0.0

EV/GP/RG

MCRBN/A

RNAZN/A

Ticker research

View MCRB research View RNAZ research

Metric	MCRB Seres Therapeutics Inc	RNAZ Transcode Therapeutics Inc
Market & Valuation
Market Cap	$26M	$2M
Enterprise Value	$11M	$-6M
Price	$2.71	$1.86
P/E Ratio	N/A	N/A
P/S Ratio	13.93x	0.00x
EV/Sales	5.65x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	0.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.21x	0.25x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-98.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3971.2%	0.0%
Net Margin (TTM)	-1192.9%	0.0%
FCF Margin (TTM)	-2724.1%	N/A
Net Income (TTM)	$-22M	$-46M
FCF (TTM)	$-51M	$-23M
EPS (TTM)	-$2.30	-$48.35
ROE (TTM)	-6032.0%	-3928.0%
ROA (TTM)	-1794.0%	-3601.0%
ROIC (TTM)	-6032.0%	-3922.0%
Financial Health
Cash	$16M	$8M
Debt	$0	$652K
Net Cash/Debt	$16M	$8M
Current Ratio (TTM)	2.11x	1.97x
Quick Ratio (TTM)	2.04x	1.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.29
52W Performance	-86.2%	-82.4%
YTD Performance	-82.1%	-74.9%
% from 52W High	-91.0%	-91.1%
% from 52W Low	12.0%	22.4%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-195.5%	-1146.9%
Earnings Yield (TTM)	-85.6%	-2347.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,724.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MCRB research	View RNAZ research